In Alzheimer’s disease, a progressive neurodegenerative disorder marked by cognitive decline and amyloid-beta plaques, NFE2L1 expression has also been implicated. The gene discussed is NFE2L1; the disease is early-onset autosomal dominant Alzheimer disease.